Board member since 2002
“While neither myself nor my family are sufferers of this indolent lymphoma, my passion for finding a cure and making sure every patient afflicted with cutaneous lymphomas gets the best care possible is as compelling today as it was in 1995, when I first came to know of this cancer.”
Michael is an accomplished, biopharmaceutical executive with award-winning marketing and commercial operations credentials. He works as a subject matter expert in clinical development and biotech commercialization. His recent work has focused on the improvement of clinical recruitment through digital disruptive technologies and solving issues facing clinical trial professionals around the globe. Michael has been Vice President of Strategy for Klick Health; Vice President of Business Development for PAREXEL International; and Vice President of Alliance Management for the global contract research organization (CRO).
A pioneer for a global Alliance Management capability for the Japanese pharma company - Eisai, Michael also spent eleven years as Executive Director of Strategic Marketing at biotech start-up - Ligand Pharmaceuticals Inc., where he oversaw the development, registration, and launch of five novel cancer drugs, including Targretin and ONTAK. His commercial career also includes sales management, marketing, and new product development positions at GSK, Adria Laboratories, and Bayer. Among his credentials, Michael was named Medical Marketer of the Year by the Medical Marketing Association and served as President of the national organization.
With an undergraduate degree from Kenyon College and graduate work at Ohio State University, Michael brings a wealth of knowledge to his volunteer position at the Cutaneous Lymphoma Foundation. His expertise in marketing and proficiency within the pharmaceutical industry have provided valuable information that helps the Foundation to advocate on behalf of patients and caregivers.